CCL5 and thyroid cancer: Further validation using qRT–PCR in 100 paired thyroid cancer and adjacent normal tissues revealed consistent upregulation of ACSL5 and NCF2 in tumour tissues and downregulation of HSD17B11, CCL5, and ACTB.